Steven Klosk - Cambrex President, Chief Executive Officer, Director
CEO
Mr. Steven M. Klosk is President, Chief Executive Officer, Director of the Company. Having joined the Company in 1992, Mr. Klosk held positions of increasing responsibility, including Executive Vice President, Administration, through 2005, when he assumed direct responsibility for the leadership of the Biopharmaceutical Business Unit as Chief Operating Officer. In August 2006, Mr. Klosk assumed the responsibility of the Pharma business as Executive Vice President and Chief Operating Officer Biopharma Pharma, and in February 2007 was appointed to Executive Vice President, Chief Operating Officer and President, Pharmaceutical Products and Services, the last role he held prior to being appointed President and Chief Executive Officer since 2008.
| Age | 61 |
| Tenure | 16 years |
| Professional Marks | Ph.D |
| Phone | 201 804-9852 |
| Web | www.cambrex.com |
Cambrex Management Efficiency
The company has Return on Asset of 8.76 % which means that on every $100 spent on assets, it made $8.76 of profit. This is considered to be average in the sector. In the same way, it shows a return on shareholders' equity (ROE) of 16.0 %, implying that it generated $16.0 on every 100 dollars invested. Cambrex's management efficiency ratios could be used to measure how well Cambrex manages its routine affairs as well as how well it operates its assets and liabilities.The company has 550.55 M in debt with debt to equity (D/E) ratio of 81.3, demonstrating that the company may be unable to create cash to meet all of its financial commitments. Cambrex has a current ratio of 2.39, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist Cambrex until it has trouble settling it off, either with new capital or with free cash flow. So, Cambrex's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Cambrex sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Cambrex to invest in growth at high rates of return. When we think about Cambrex's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 13 records | CEO Age | ||
| Chet Burchett | Relx PLC ADR | N/A | |
| Hugh Jones | Relx PLC ADR | N/A | |
| Feng Zhou | Youdao Inc | 46 | |
| Erik Engstrom | Relx PLC ADR | 61 | |
| Mike Rusbridge | Relx PLC ADR | N/A | |
| MSc Econ | Relx PLC ADR | 61 | |
| Kumsal Besson | Relx PLC ADR | 50 | |
| Mike Walsh | Relx PLC ADR | N/A | |
| Ron Mobed | Relx PLC ADR | 57 | |
| Boris Elisman | Acco Brands | 61 | |
| Mark Kelsey | Relx PLC ADR | N/A | |
| Christian Hogg | HUTCHMED DRC | 48 | |
| John Adent | Neogen | 56 | |
Management Performance
| Return On Equity | 16.0 | |||
| Return On Asset | 8.76 |
Cambrex Leadership Team
Elected by the shareholders, the Cambrex's board of directors comprises two types of representatives: Cambrex inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cambrex. The board's role is to monitor Cambrex's management team and ensure that shareholders' interests are well served. Cambrex's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cambrex's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Aldo Magnini, Managing Director of Cambrex Profarmaco Milano | ||
| Bernhard Hampl, Independent Director | ||
| Shlomo Yanai, Non-Executive Chairman of the Board | ||
| Gregory Sargen, Chief Financial Officer, Executive Vice President, Corporate Development and Strategy | ||
| Dottie Brienza, Chief Human Resource Officer, Senior Vice President | ||
| Samantha Hanley, Vice President, General Counsel,Corporate Secretary | ||
| Louis Grabowsky, Independent Director | ||
| James Farrell, Vice President and Corporate Controller | ||
| Claes Glassell, Independent Director | ||
| Gregory Brown, Independent Director | ||
| Rosina Dixon, Independent Director | ||
| Steven Klosk, President, Chief Executive Officer, Director | ||
| Leon Hendrix, Independent Director | ||
| Tom Vadaketh, CFO, Executive Vice President | ||
| Ilan Kaufthal, Independent Director | ||
| William Korb, Independent Director | ||
| Stephanie LaFiura, Investors Relations Associate | ||
| Shawn Cavanagh, Chief Operating Officer, Executive Vice President | ||
| Peter Tombros, Independent Director | ||
| Kathryn Harrigan, Independent Director | ||
| William Haskel, Chief Compliance Officer, Sr. VP, General Counsel and Corporate Secretary |
Cambrex Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cambrex a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 16.0 | |||
| Return On Asset | 8.76 | |||
| Profit Margin | 13.88 % | |||
| Operating Margin | 25.54 % | |||
| Current Valuation | 2.5 B | |||
| Shares Outstanding | 33.66 M | |||
| Shares Owned By Insiders | 0.83 % | |||
| Shares Owned By Institutions | 99.17 % | |||
| Number Of Shares Shorted | 2.73 M | |||
| Price To Earning | 55.24 X |
Pair Trading with Cambrex
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cambrex position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cambrex will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Xylem could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Xylem when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Xylem - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Xylem Inc to buy it.
The correlation of Xylem is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Xylem moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Xylem Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Xylem can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Cambrex information on this page should be used as a complementary analysis to other Cambrex's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Consideration for investing in Cambrex Stock
If you are still planning to invest in Cambrex check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cambrex's history and understand the potential risks before investing.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Commodity Directory Find actively traded commodities issued by global exchanges |